Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
CA 2299560 C · Owner: Bougueleret, Lydie · Inventors: Bougueleret, Lydie; Chumakov, Ilya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a novel human polypeptide defensin homologous of HNP-4, its genomic DNA and DNAc vectors, cells transformed by said vectors the use of said polypeptide as antibiotic cytotoxic, repairing and endocrine regulating agent or as pesticide as well as cosmetic or pharmaceutical compositions for treating microbial infections in particular bacterial, fungal, and viral or parasitic, cancers, inflammation and immunodeficiency. The invention also concerns diagnostic methods and kits for determining a microbial or parasitic infection and an inflammation or for detecting predisposition to immunodeficiency or cancerous diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 28, 1998 and granted March 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 28, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.